Buttock · Procedure
The buttock is read against everything around it. Against the waist above, the lower back that runs into it, the lateral line of the hip and the fold beneath. Add volume without changing any of those and you get a larger buttock in the same silhouette — which is almost never what the patient meant.
Most of the work in this operation is not the injection. It is the liposuction of the flank, the lower back and the sacral region that creates the frame the volume will be seen against, and the decision about where in the buttock that volume is allowed to go. The second of those has been the subject of the most serious safety debate in aesthetic surgery of the last decade, and this page does not skip it.
The Frame
Ask what makes a buttock look full and most people will point at the buttock. The measurable answer is more interesting. When 989 people were asked to rate gluteal silhouettes, the most attractive posterior view was a waist-to-hip ratio of 0.65, chosen by 44.2 per cent, with 0.60 next. On the side view the preferred ratio was 0.70, and the most attractive position for the point of greatest projection was the vertical midpoint of the buttock — not the top, not the bottom. Preferences did not differ significantly by the respondent’s age, sex or ethnicity.
Read that as an instruction and it says something specific: the ratio is a fraction, and the numerator is not the only variable. Narrowing the waist changes the ratio without adding a single cubic centimetre to the buttock. In practice both are done, and the liposuction half is frequently the half that produces the photograph.
The Decision
Two ways to add volume, with genuinely different profiles. What follows is the comparison as the literature actually reports it, including the part that undermines the comparison.
| Route | What it does well | What it cannot do |
|---|---|---|
| Autologous fat transfer ¥1,265,000 |
Your own tissue, so it feels like you. It improves two places at once — the donor area is part of the silhouette, not a supply run. It shapes: fat can be placed to widen the upper lateral quadrant, soften the trochanteric depression or lift the transition, which a device cannot do. Lower reported complication rates than implants in every comparative review. | It cannot be done without enough donor fat, and a slim patient often has the strongest aesthetic case for it and the least of it available. It cannot be promised as a final volume — a substantial fraction does not survive. It carries a specific and serious risk that implants do not, discussed below. |
| Silicone implant ¥1,540,000 |
A defined volume delivered on the day, independent of how much fat you have. The route for a patient with no usable donor site, and for projection at the central buttock that grafting cannot reliably reach in one session. | It cannot shape the periphery, so it is rarely the whole plan. It sits in a region that is sat on, walked on and slept on, and the complication profile reflects that: wound dehiscence is reported at rates an order of magnitude above what patients expect. It is a device with a service life. |
| Composite ¥1,870,000 |
An implant for central projection with fat placed around it for the transitions the implant cannot make. The commonest approach where a patient wants substantial projection and has limited donor fat. | It cannot remove the implant from the equation. Every implant consideration still applies, and the graft’s considerations are added to them. |
In a systematic review of 44 articles covering 2,375 implant patients and 3,567 fat-grafting patients, overall complication rates were 21.6 per cent for implants and 9.9 per cent for fat. A separate review of 4,362 patients found 31.4 per cent for implants, 6.8 per cent for fat and 23.1 per cent for local flaps. Both papers say plainly what a reader should hold onto: there has never been a head-to-head trial. These are pooled retrospective series with different patients in each arm, and the difference cannot be treated as causal.
Fat
This is the number to ask about, and it is smaller than the internet suggests. Two prospective studies with objective imaging give the most honest available picture.
Those two are not measuring the same thing, which is the point. One measures volume by surface imaging, the other measures a layer’s thickness by ultrasound. Neither is volumetry. We searched for magnetic resonance or computed tomography volumetric measurement of buttock fat graft retention and found none published, and we found no study at all following grafted buttock volume beyond twelve months, or examining what happens to it when the patient subsequently gains or loses weight. A clinic that quotes you a precise multi-year retention figure is quoting something that has not been measured.
What can be said usefully: plan on keeping roughly two thirds of what is placed, expect the number to be settled by six months, and understand that grafted fat behaves like the fat it came from — it will gain and lose with your body weight for the rest of your life.
The Plane
Fat is placed in the subcutaneous layer, above the gluteal fascia. Never into the muscle, never below it. That sentence is the whole of this operation’s safety, and the reason it is written so flatly is that the alternative killed people.
The anatomy explains it. In a cadaveric study mapping 20 gluteal regions in three dimensions, the subcutaneous plane contains around 25 vessels, all small — arteries averaging 0.9 mm and veins 1.05 mm in diameter. Go deeper and the calibre changes by an order of magnitude: the superior gluteal vein trunk measured 7.6 mm and the inferior gluteal vein 13.7 mm. A vein wide enough to accept a lobule of fat is a vein wide enough to deliver it to the lung.
Two dynamic cadaveric studies then showed what actually happens. When fat proxy was injected into the muscle, it migrated through into the deep submuscular space in every specimen; when injected subcutaneously with the fascia intact, none was found in the muscle or beneath it. A second study measured the pressure: with the fascia intact, subcutaneous pressure plateaued and everything stayed where it was put; where the fascia had been breached by 6 mm defects, pressure fell away and significant proxy fat was found in the submuscular space. The conclusion the authors reached, and the one followed here, is that there is no such thing as a safely superficial intramuscular injection.
Three things about the buttock in particular are worth knowing beyond that.
Implants
Gluteal implants avoid the fat-embolism question entirely, and they carry a different set of problems that are easy to underestimate because the breast is the reference most people have. The buttock is not the breast. It is loaded every time you sit down, the incision sits close to the intergluteal cleft, and the tissue over the device is muscle rather than gland.
The device used here is a Motiva gluteal implant, placed through a single incision of approximately five centimetres running along the intergluteal cleft, where the scar falls in a natural shadow rather than across the visible surface of the buttock. One incision for both sides is deliberate: it keeps the scar in the one place on the buttock that is never on display, and it avoids two separate wounds in a region that moves. The trade-off is that it is also a region that is difficult to keep clean and impossible to keep still, which is why the closure matters more here than the choice of device.
| Study | Finding |
|---|---|
| Systematic review and meta-analysis of primary implant-based gluteal augmentation, 32 studies, 2,682 patients | Textured against smooth shells: seroma 7.50 versus 2.56 per cent, dehiscence 13.98 versus 6.63 per cent, capsular contracture 2.06 versus 0.55 per cent. By plane, subfascial was worst by a distance — seroma 22.25 per cent, dehiscence 27.07 per cent, implant removal 5.23 per cent. Overall implant removal 1.05 per cent. Intramuscular and submuscular placement performed better. |
| Single-surgeon series, 200 consecutive patients, 400 implants, mean follow-up 3 years | Seroma 28 per cent, infection 6.5 per cent of patients, wound dehiscence 1.5 per cent, capsular contracture 1 per cent, reoperation 13 per cent. Patients with intramuscular implants more often reported a lack of lower gluteal fullness. |
| Multicentre survey of 2,226 implant patients | Total complications reported at 38.1 per cent. This is the historical high-water mark and is widely quoted; it came from a survey to which only 19 of 83 surgeons responded, so treat it as an upper bound rather than an estimate. |
| Meta-analysis of combined implant and lipoplasty (composite) augmentation, 13 studies | Pooled implant removal 1.70 per cent. Intramuscular plane: dehiscence 14.56 per cent. Submuscular plane: sciatic neuropathy 3.91 per cent. Drain use was associated with more seroma and less infection, in both directions. |
| Single-surgeon composite series, 423 patients, follow-up 21 to 55 months | Overall implant-related complication rate 10.8 per cent, seroma the most frequent. |
| Controlled sensory testing, 20 patients versus 20 unoperated controls | No difference in touch, heat, cold, pain, vibration or pressure sensation after intramuscular gluteal augmentation. Small study; it cannot exclude a small effect. |
The figure to carry away is dehiscence. A wound that opens over a silicone device, in a region that cannot be kept still and sits next to the natal cleft, is the complication that turns a straightforward operation into a long one. It is why the pocket plane is chosen conservatively, why the incision is placed and closed the way it is, and why an implant is not offered to a patient who has adequate donor fat and wants a moderate change.
Candidacy
The Operation
Recovery
Evidence
The least flattering figures are included deliberately, including those that concern this operation’s safety record.
| Study | Finding |
|---|---|
| Prospective three-dimensional and ultrasound study, 35 patients, subcutaneous plane | Fat retention 77.9 per cent at three months, 64.7 per cent at six months. Adipose thickness fell 5.1 per cent at three months and 15.1 per cent at six. Waist-to-hip ratio 0.78 to 0.74. |
| Prospective ultrasound study, 50 patients, subcutaneous only, 12 months | Subcutaneous thickness increased a mean 56.5 per cent immediately after surgery, then decreased a mean 18.2 per cent by twelve months. |
| Systematic review and meta-analysis of gluteal fat grafting, 38 studies, 22,151 patients | Pooled minor complications 3.58 per cent; seroma 2.03 per cent; contour irregularity 2.29 per cent; pulmonary embolism 0.04 per cent. Ultrasound-guided against not: major complications 0.02 versus 0.08 per cent. Subcutaneous-only injection had the lowest rates. Lipoaspirate additives and drains did not consistently lower complication rates and were sometimes associated with worse outcomes. |
| Earlier meta-analysis of gluteal fat grafting, 19 articles, 4,105 patients | Mean complication rate 7 per cent (6.7 minor, 0.32 major), with no significant relationship to the plane of injection. Included here because it is a clean example of evidence being overturned: later cadaveric and survey work reversed this conclusion entirely. |
| Retrospective study of ultrasound-guided gluteal fat transfer, 1,815 patients | Postoperative complications in 4 per cent: seroma 1.2, local skin ischaemia 1.2, surgical site infection 0.8 per cent. No macroscopic fat emboli and no mortality. |
| Scoping review of ultrasound in gluteal fat grafting, 9 studies | “No randomized or high-quality comparative studies were identified.” Evidence is predominantly observational; verification of the injection plane relied mainly on intraoperative visualisation rather than standardised imaging confirmation. |
| Comparative measurement study, 200 patients, guided against unguided | Mean variation in lateral projection 2.04 against 2.81 per cent — described by the authors themselves as minimal. The case for guidance is safety, not aesthetics. |
| Cadaveric latex-cast vascular mapping, 20 gluteal regions | Subcutaneous plane: about 25 vessels, arteries 0.9 mm and veins 1.05 mm. Superior gluteal vein trunk 7.61 mm; inferior gluteal vein trunk 13.65 mm. |
| Dynamic cadaveric migration study, 8 hemibuttocks | Proxy fat migrated through muscle into the deep submuscular space with every intramuscular injection; with subcutaneous injection none was found in the muscle or beneath it. |
| Meta-analysis of intramuscular fat grafting, 27 studies, 208,692 observations | Pooled complication rate 6.2 per cent with very high heterogeneity. Fat embolism mortality reported at 1 in 3,000 for gluteal intramuscular fat grafting. |
| Systematic review of implant-based gluteal augmentation, 32 studies, 2,682 patients | Textured against smooth: seroma 7.50 versus 2.56 per cent; dehiscence 13.98 versus 6.63 per cent. Subfascial plane: seroma 22.25 per cent, dehiscence 27.07 per cent, removal 5.23 per cent. Overall removal 1.05 per cent. |
| Single-surgeon implant series, 200 patients, 400 implants | Seroma 28 per cent, infection 6.5 per cent, reoperation 13 per cent, capsular contracture 1 per cent. |
| Meta-analysis of composite implant and fat augmentation, 13 studies | Implant removal 1.70 per cent. Intramuscular dehiscence 14.56 per cent; submuscular sciatic neuropathy 3.91 per cent. |
| Systematic review comparing techniques, 44 articles | Overall complications 21.6 per cent for implants against 9.9 per cent for fat. Patient satisfaction was measured too differently across studies to be compared. |
| Systematic review of 4,362 gluteoplasty patients | Overall 12.4 per cent. Implants 31.4 per cent, local flaps 23.1 per cent, fat grafting 6.8 per cent. No randomised comparison exists; selection differs between arms. |
| Forensic autopsy series, 35 deaths after body-contouring surgery, 2022–2024 | Pulmonary thromboembolism in 65.7 per cent and deep vein thrombosis in 40 per cent, exceeding pulmonary fat embolism at 68.6 per cent on histology. 85.7 per cent had multiple simultaneous procedures; body mass index was significantly higher in the thromboembolic deaths. |
| Ultrasound study of gluteal subcutaneous thickness, 150 individuals | Each unit of body mass index corresponds to roughly 3 mm additional subcutaneous thickness in men and 4 mm in women. Ageing thickens the deep layer, rising body mass index the superficial one. |
| Population preference study, 989 gluteal ratings | Most attractive posterior waist-to-hip ratio 0.65 (44.2 per cent); lateral 0.70 (29.8 per cent); point of maximum projection at the vertical midpoint (45.1 per cent). No significant differences by respondent age, sex or ethnicity. |
These figures describe published study populations authored by others. They do not describe results at this practice and are not a prediction of your individual outcome. Full citations are listed at the foot of this page.
Fees
| Procedure | Fee (JPY, incl. tax) |
|---|---|
| Gluteal fat transfer | ¥1,265,000 |
| Fat harvest and processing, additional donor area | ¥220,000 |
| Gluteal implant (silicone) | ¥1,540,000 |
| Composite augmentation (implant with fat transfer) | ¥1,870,000 |
| Contouring of the surrounding frame | |
| Liposuction, per area (flank, lower back, sacral region) | From ¥275,000 |
| Additional | |
| General anaesthesia | ¥165,000 |
| Standard set (anaesthetic, medication, compression garment) | ¥66,000 |
| Blood tests | ¥11,000 |
| Body mass index surcharge, 25 to 30 | ¥55,000 |
| Body mass index surcharge, over 30 | ¥110,000 |
All figures are standard prices, not monitor prices, current as of August 2026 and subject to change. Which surrounding areas are included is decided at consultation and is part of the plan rather than an upsell — the full area schedule is on the HD VASER Liposuction page. Your written quotation is the binding figure and is issued before you book travel. See the full fee schedule and process for international patients.
Guarantee
The one-year guarantee at this practice applies to VASER liposuction, VASER 4D, Condense Rich fat transfer breast augmentation, mastopexy and gynaecomastia correction. Gluteal fat transfer is not covered by it, and neither are gluteal implants.
The reason is the same reason the retention figures above are given as a range rather than a promise: how much grafted fat survives in the buttock depends on your circulation, your tissue and your body weight over the following year, and none of those is something a surgeon can underwrite. Where liposuction of the surrounding areas is performed as part of the same plan, the liposuction component falls under the guarantee on its own terms. We would rather set the boundary out plainly than let you assume it covers everything.
Risks
This is elective surgery, it is not covered by health insurance in Japan, and its outcome cannot be guaranteed. Gluteal fat grafting has been associated with a higher mortality rate than any other aesthetic surgical procedure, and that fact belongs at the top of this list rather than buried in it.
Questions
Gluteal fat transfer is the operation usually marketed under that name. The name is a marketing term rather than a technical one, and it has attached itself to a very wide range of practice — including, historically, the intramuscular injection technique that caused the deaths this procedure became known for. What is performed here is subcutaneous-only fat placement under real-time ultrasound guidance, which is a different operation from the one the name is associated with.
It has been associated with a higher mortality rate than any other aesthetic surgical procedure, and that is a direct quotation from the task force report rather than our characterisation. What changed the picture was the plane: reported mortality moved from around 1 in 3,448 to 1 in 14,952 in the two years after guidance recommending subcutaneous-only injection, alongside a fall in surgeons injecting into deep muscle from 13.1 per cent to 0.8 per cent. Those figures come from voluntary anonymous surveys rather than registries, and the authors themselves call the mortality change a trend rather than a proven reduction. The operation is safer than it was. It is not risk-free, and the honest way to reduce your own risk is to ask any surgeon anywhere exactly which plane they inject into and how they verify it.
Around two thirds, on the best objective evidence. In a prospective three-dimensional imaging study of 35 patients, retention was 77.9 per cent at three months and 64.7 per cent at six. A twelve-month ultrasound study of 50 patients found roughly four fifths of the immediate gain retained at one year. Nobody has measured buttock graft retention by MRI or CT, and nobody has published a follow-up beyond one year. A precise multi-year figure quoted to you is not a measurement.
This is the constraint that ends the conversation most often, and it works in an unintuitive direction: the slimmest patients frequently have the strongest aesthetic case for the operation and the least fat available for it. It is assessed by examination rather than from photographs. Where there is not enough for the change you want, the honest alternatives are a smaller change, an implant, or a composite approach — and that is said before you book travel, not after.
Fat where there is enough of it, in almost every case, because it shapes the periphery and an implant cannot. Every comparative review reports lower complication rates for fat — 9.9 against 21.6 per cent in one, 6.8 against 31.4 per cent in another — though there has never been a head-to-head trial and the patients in each arm are not comparable. An implant earns its place where donor fat is genuinely insufficient, or where central projection is wanted beyond what grafting can deliver in one session. In practice the two are often combined.
The wound opening. Dehiscence is reported between roughly 6.6 and 27 per cent depending on the plane and the implant surface, which is an order of magnitude above what most patients expect, and it is the specific reason the pocket plane, the five-centimetre incision along the cleft and the layered closure are chosen the way they are. Seroma is close behind — 28 per cent in one experienced single-surgeon series of 400 implants. This is a region that is sat on and walked on; it does not get to rest.
Partly, and the honest answer involves saying what the depression actually is. It is a fixed attachment between the skin and the underlying bone at the level of the greater trochanter, which is why it does not respond to exercise and why it cannot be removed. What can be done is to add volume above and below it so that it reads as a curve rather than an angle. We searched for anatomical or outcome studies on hip-dip correction specifically and found none published, so what you will be told here is a surgical judgement rather than a cited result.
You will be asked to limit and cushion it, and you should. You should also know that no controlled study has ever compared sitting restriction against no restriction for buttock fat grafting — we looked, and the evidence does not exist. The instruction rests on mechanism and convention. The mechanism is plausible, the cost of following it is a fortnight of inconvenience, and we would rather tell you which parts of your aftercare are proven and which are merely reasonable.
Some of it must be — the liposuction that creates the frame is part of the same operation. Beyond that, combining is approached cautiously rather than enthusiastically. In a forensic series of 35 deaths after body-contouring surgery, 85.7 per cent of the patients had undergone multiple procedures in a single session, and pulmonary thromboembolism was the most frequent cause. Operating time and combined load are themselves a risk. Where a plan needs more than one operation, it is staged and the staging is written down before you book anything.
Yes. Grafted fat is your own fat and it behaves like the rest of it — it will shrink if you lose weight and enlarge if you gain. There is no published study following grafted buttock volume through a significant weight change, so nobody can tell you by how much. The practical implication is to have the operation when your weight is stable rather than in the middle of changing it.
Some numbness over the buttock is common early and usually temporary. In a controlled study comparing 20 patients after intramuscular gluteal implant augmentation with 20 unoperated controls, there was no measurable difference in touch, heat, cold, pain, vibration or pressure sensation. That study is small and cannot exclude a subtle effect, but there is no evidence of a persistent sensory deficit as a routine outcome.
Plan for at least two weeks after surgery. That covers the early phase and at least one in-person follow-up before you are cleared to fly. Given that thromboembolism is the leading cause of death in this category of surgery and that long-haul flight adds to that risk, clearance to travel here is a clinical judgement rather than a date agreed in advance. Your arrival date before surgery is set separately in your written plan.
Gluteal fat transfer is ¥1,265,000 including tax, covering two donor areas. A silicone implant is ¥1,540,000 and composite augmentation ¥1,870,000. Fat harvest and processing from an additional donor area is ¥220,000, and liposuction of the surrounding frame is charged per area from ¥275,000. General anaesthesia, the standard post-operative set and blood tests are additional, and a body mass index surcharge applies above 25. Your written quotation states the total and is issued before you book travel.
No. The guarantee covers VASER liposuction, VASER 4D, Condense Rich fat transfer breast augmentation, mastopexy and gynaecomastia correction. Gluteal fat transfer and gluteal implants are not included — how much grafted fat survives depends on your circulation and your body weight over the following year, and that is not something a surgeon can underwrite. Where liposuction of the surrounding areas is part of the same plan, that component falls under the guarantee on its own terms.
References
Retrieved from PubMed. The figures quoted above come from these studies, which describe study populations authored by others rather than results at this practice.
Next
The consultation is held online, in English, before you commit to any travel. You will be told how much donor fat you actually have, which of the surrounding areas need to be treated to make the change visible, whether a device belongs in the plan, and where the honest limit sits.